OIG - Office of Inspector General
12/17/2025 | Press release | Distributed by Public on 12/17/2025 09:37
Digital Health Company and Medical Practice Indicted in $100M Adderall Distribution Scheme
Digital Health Company and Medical Practice Indicted in $100M Adderall Distribution Scheme
The Digital Health Company Was Also Charged with Health Care Fraud and Obstruction Conspiracies
A federal grand jury in San Francisco returned an indictment yesterday charging a California company for its participation in a years-long scheme to illegally distribute Adderall over the internet, conspire to commit health care fraud in connection with the submission of false and fraudulent claims for reimbursement for Adderall and other stimulants, and conspire to obstruct justice. A Florida medical practice was also charged in connection with its alleged participation in the scheme to illegally distribute Adderall.
Read more on https://www.justice.gov
Action Details
- Date:December 17, 2025
- Agency:U.S. Department of Justice
-
Enforcement Types:
- Criminal and Civil Actions
OIG - Office of Inspector General published this content on December 17, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on December 17, 2025 at 15:37 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]